allergic reaction

Metallic arrow symbols illuminated by blue and magenta lights forming a graph on blue and magenta background
Biotech

Excellergy emerges with $70M and ex-Dermavant CEO at the helm

The California biotech is developing a new drug class in hopes of redefining the standard of care for several allergic diseases.
Gabrielle Masson Oct 13, 2025 10:50am
Photo of rough waves crashing in the ocean

Aldeyra forewarns potential FDA rejection for dry eye med

Oct 16, 2023 2:49pm
Person scratching

Third Harmonic Bio raises $105 million series B

Feb 16, 2022 7:00am